Comparative Pharmacology
Head-to-head clinical analysis: HC 1 versus TRIDESILON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HC 1 versus TRIDESILON.
HC #1 vs TRIDESILON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Unknown
Desonide is a corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It acts by inducing phospholipase A2 inhibitory proteins, collectively called lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of arachidonic acid from membrane phospholipids.
Hydrocortisone: 100-200 mg IV as initial dose, then 50-100 mg IV every 6 hours, or 0.18 mg/kg/h IV continuous infusion.
0.05% ointment or cream applied topically to affected area twice daily.
None Documented
None Documented
2–4 hours (terminal); prolonged in renal impairment.
2–3 hours (topical); 1–2 hours (systemic) after IV, with clinical duration prolonged due to tissue binding.
Renal: 90% as unchanged drug; fecal: 10%.
Primarily hepatic metabolism; metabolites excreted renally (70%) and in feces (30%).
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid